Division of Cancer Treatment and Diagnosis

E16765

The Division of Cancer Treatment and Diagnosis is a branch of the National Cancer Institute that supports the development, evaluation, and clinical testing of new cancer therapies and diagnostic tools.

AI illustration

How this image was made

AI-generated illustration of Division of Cancer Treatment and Diagnosis

This AI-generated illustration was produced by black-forest-labs/FLUX.2-dev (1024x1024) from a prompt written by openai/gpt-oss-120b from the entity's label + description.

Prompt

Generate an image of the Division of Cancer Treatment and Diagnosis (The Division of Cancer Treatment and Diagnosis is a branch of the National Cancer Institute that supports the development, evaluation, and clinical testing of new cancer therapies and diagnostic tools.)

All labels observed (1)

Label Occurrences
Division of Cancer Treatment and Diagnosis canonical 1

How this entity was disambiguated

Statements (45)

Predicate Object
instanceOf division of a government agency ⓘ
research organization unit ⓘ
affiliation U.S. Department of Health and Human Services ⓘ
country United States ⓘ
field cancer research ⓘ
clinical oncology ⓘ
drug development ⓘ
medical diagnostics ⓘ
oncology ⓘ
translational research ⓘ
focus biomarker development ⓘ
cancer diagnosis ⓘ
cancer treatment ⓘ
clinical trials ⓘ
combination cancer therapies ⓘ
early-phase clinical trials ⓘ
imaging technologies for cancer ⓘ
precision oncology ⓘ
therapeutic development ⓘ
translational clinical research ⓘ
goal to accelerate translation of laboratory discoveries into clinical applications ⓘ
to expand access to innovative cancer treatments through clinical trials ⓘ
to facilitate regulatory approval of effective cancer therapies ⓘ
to improve outcomes for cancer patients ⓘ
jurisdiction federal government of the United States ⓘ
locatedIn Bethesda, Maryland ⓘ
mission to support the clinical testing of new cancer diagnostic tools ⓘ
to support the clinical testing of new cancer therapies ⓘ
to support the development of new cancer diagnostic tools ⓘ
to support the development of new cancer therapies ⓘ
to support the evaluation of new cancer diagnostic tools ⓘ
to support the evaluation of new cancer treatments ⓘ
operatedBy National Cancer Institute ⓘ
parentOrganization National Cancer Institute ⓘ
National Institutes of Health ⓘ
partOf National Cancer Institute ⓘ
sector public sector ⓘ
supports clinical trial networks ⓘ
cooperative research groups ⓘ
development of anticancer drugs ⓘ
development of biologic cancer therapies ⓘ
development of cancer diagnostic assays ⓘ
development of cancer imaging agents ⓘ
investigator-initiated clinical trials ⓘ
website https://dctd.cancer.gov/ ⓘ

How these facts were elicited

Referenced by (1)

Full triples — surface form annotated when it differs from this entity's canonical label.

National Cancer Institute → hasDivision → Division of Cancer Treatment and Diagnosis ⓘ